FDA NDC Directory · JSON-LD · Markdown

DURYSTA

NDC 0023-9652 · HUMAN PRESCRIPTION DRUG · IMPLANT

Generic namebimatoprost
Labeler / ManufacturerAllergan, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA211911
Dosage form / routeIMPLANT · INTRACAMERAL
Active ingredientsBIMATOPROST (10 ug/1)
Marketing started20200304
Package count2

External sources

Source: openFDA. Public-domain (CC0).